Hallelujah! Dark chocolate promotes arterial healthPlant chemicals found in this seemingly sinful food item actually reduce blood pressure and improve blood flow Volibris for pulmonary arterial hypertensionGlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease. Chronic kidney disease: new management guidelines The Canadian Society of Nephrology has developed new guidelines for the management of chronic kidney disease (CKD). Angeliq: continuous therapy for menopausal symptoms Bayer is introducing Angeliq (drospirenone 1 mg and estradiol-17 Clincal in Brief - Nov 4 2008 New Brunswick pharmacists win prescribing authority Amendments to the Pharmacy Act that expand the role of pharmacists come into effect today. Practice Issues: Adverse reactions - ACEI- and ARB-induced angioedema Angioedema is a self-limiting, nonpitting edema that occurs in the skin and mucous membranes. Trends and Insights: Going Coastal What’s on the minds of pharmacists across the country? Practice Issues: Research highlights - Folate/B vitamins for preventing cardiovascular disease Study examines effects of daily combination of folic acid, vitamin B6 and vitamin B12 on the occurrence of cardiovascular events among women with and without a history of CVD. Practice Issues: Research highlights – Antihypertensives and progression of chronic kidney disease Study measures long-term effect of ACEIs in conjunction with low blood pressure goal in the treatment of African-Americans with CKD. First Previous 93 94 95 Next Last
